OSTIN TECHNOLOGY GROUP CO LT (OST)

KYG679271067 - Common Stock

0.41  -0.05 (-10.54%)

After market: 0.45 +0.04 (+9.76%)

Fundamental Rating

0

Overall OST gets a fundamental rating of 0 out of 10. We evaluated OST against 127 industry peers in the Electronic Equipment, Instruments & Components industry. OST may be in some trouble as it scores bad on both profitability and health. OST has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year OST has reported negative net income.
In the past year OST has reported a negative cash flow from operations.
Of the past 5 years OST 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: OST reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -28.18%, OST is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
With a Return On Equity value of -114.19%, OST is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -28.18%
ROE -114.19%
ROIC N/A
ROA(3y)-4.98%
ROA(5y)-1.7%
ROE(3y)-18.67%
ROE(5y)-3.9%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 2.99%, OST is doing worse than 86.51% of the companies in the same industry.
OST's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.45%
GM growth 5Y-13.37%

0

2. Health

2.1 Basic Checks

OST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OST has about the same amount of shares outstanding.
The number of shares outstanding for OST remains at a similar level compared to 5 years ago.
OST has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that OST is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of OST (0.30) is worse than 73.02% of its industry peers.
OST has a Debt/Equity ratio of 1.83. This is a high value indicating a heavy dependency on external financing.
OST has a Debt to Equity ratio of 1.83. This is amonst the worse of the industry: OST underperforms 92.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.83
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACCN/A
WACC5.93%

2.3 Liquidity

OST has a Current Ratio of 0.60. This is a bad value and indicates that OST is not financially healthy enough and could expect problems in meeting its short term obligations.
OST's Current ratio of 0.60 is on the low side compared to the rest of the industry. OST is outperformed by 94.44% of its industry peers.
OST has a Quick Ratio of 0.60. This is a bad value and indicates that OST is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of OST (0.25) is worse than 96.03% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.25

0

3. Growth

3.1 Past

The earnings per share for OST have decreased strongly by -1175.74% in the last year.
The Revenue for OST has decreased by -44.52% in the past year. This is quite bad
OST shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.33% yearly.
EPS 1Y (TTM)-1175.74%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-4725.5%
Revenue 1Y (TTM)-44.52%
Revenue growth 3Y-25.67%
Revenue growth 5Y-1.33%
Revenue growth Q2Q-45.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OST. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for OST!.
Industry RankSector Rank
Dividend Yield N/A

OSTIN TECHNOLOGY GROUP CO LT

NASDAQ:OST (4/25/2024, 4:28:01 PM)

After market: 0.45 +0.04 (+9.76%)

0.41

-0.05 (-10.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.89M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.18%
ROE -114.19%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 2.99%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 1.83
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.6
Quick Ratio 0.25
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1175.74%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-44.52%
Revenue growth 3Y-25.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y